Category: Q&A

Characterizing Severe Autoimmune Toxicities Associated with Checkpoint Inhibitor Therapies

Immune checkpoint inhibitors (ICI) have emerged as powerful tools against cancer but in some cases have caused inflammation of organ systems that contributed to morbidity or mortality in patients. The molecular underpinnings of toxicities from immune checkpoint inhibitors are not...

/ March 31, 2017

Monitoring Clinically Actionable Proteins- A Q&A with Gordon Mills, MD Anderson Cancer Center

NanoString sat down with Gordon Mills, M.D., Ph.D., Chair of Systems Biology Department at MD Anderson Cancer Center in Houston and lead developer of The Cancer Proteome Atlas (TCPA), to talk about the value of cataloging proteins and the future...

/ March 20, 2017